Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2024-03-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
独立董事2023年度述职报告（周睿）
Board/Management Information Classification · 95% confidence The document is titled '独立董事2023 年度述职报告' which translates to 'Independent Director 2023 Annual Work Report'. It is a detailed report by an independent director about their duties, attendance at board meetings, communication with auditors, and oversight activities during the year 2023. The content focuses on the independent director's role, activities, and opinions on company governance and compliance, rather than financial results or audit opinions alone. It is not a full annual report (10-K), audit report (AR), or a regulatory announcement. It is a management-related report specifically from the independent director about their work and governance oversight. This fits best under Board/Management Information (MANG), which includes announcements or reports related to board or senior management activities and changes. The document length and detail confirm it is a substantive report, not a brief announcement or certification. Therefore, the classification is MANG with high confidence.
2024-03-29 Chinese
关于收购保定市收骏科技有限公司100%股权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement by Tianjin Ruipu Biotechnology Co., Ltd. regarding the acquisition of 100% equity of Baoding Shoujun Technology Co., Ltd., which is an affiliated transaction. It includes comprehensive information about the transaction, parties involved, financial data, legal considerations, and approvals. The document is an official announcement of a capital acquisition and related party transaction, focusing on the financing and capital structure changes due to the acquisition. It is not a full annual or interim report, audit report, or earnings release. It is not a simple announcement of a report publication but a substantive disclosure about a financing/capital transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-03-29 Chinese
关于召开2023年年度股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of Tianjin Ringpu Bio-technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on, registration details, and proxy voting forms. The document does not contain the actual annual report, financial statements, or audit reports but rather the notification and procedural details for the AGM. The presence of agenda items such as approval of the 2023 annual report and financial statements indicates this is an AGM notice. The document length is about 4897 characters, which is consistent with a detailed meeting notice rather than a full report. Therefore, the correct classification is AGM Information (AGM-R).
2024-03-29 Chinese
关于为宠物业务经销商提供担保的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Tianjin Ruipu Biotechnology Co., Ltd. regarding providing guarantees for loans to pet business distributors. It details the board and supervisory committee approvals, the guarantee amounts, risk control measures, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial performance data but is a regulatory announcement about a specific corporate action (providing guarantees). It references regulatory guidelines and internal approvals but is not a full financial report or earnings release. The document length is about 3405 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-08 Chinese
第五届董事会第十二次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board of directors meeting of Tianjin Ruipu Biotechnology Co., Ltd. It details the meeting date, attendance, agenda items, and voting results on specific business matters such as asset pool business continuation and guarantees for pet business dealers. The document does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is an official announcement of board decisions, specifically about guarantees and business operations, which fits the category of Board/Management Information (MANG). The document length is short (1555 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2024-03-08 Chinese
关于公司及子公司继续开展资产池业务并提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Tianjin Ruipu Biotechnology Co., Ltd. regarding the continuation of asset pool business and provision of guarantees by the company and its subsidiaries. It includes detailed descriptions of the business, risk control measures, financial data of the involved companies, board and supervisory opinions, and compliance with regulatory requirements. The document references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules. It is a formal disclosure about financing activities involving asset pools and guarantees, with no indication that it is a full financial report, audit report, or earnings release. The document is not a report publication announcement since it contains substantive content and detailed financial data. It is not a management report or investor presentation but rather an update on capital/financing activities and guarantees. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-03-08 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.